Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

563 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Triple Therapy-Based on Tegoprazan, a New Potassium-Competitive Acid Blocker, for First-Line Treatment of Helicobacter pylori Infection: A Randomized, Double-Blind, Phase III, Clinical Trial.
Choi YJ, Lee YC, Kim JM, Kim JI, Moon JS, Lim YJ, Baik GH, Son BK, Lee HL, Kim KO, Kim N, Ko KH, Jung HK, Shim KN, Chun HJ, Kim BW, Lee H, Kim JH, Chung H, Kim SG, Jang JY. Choi YJ, et al. Among authors: kim ji, kim jm, kim ko, kim sg, kim bw, kim n, ko kh, kim jh. Gut Liver. 2022 Jul 15;16(4):535-546. doi: 10.5009/gnl220055. Epub 2022 Jul 6. Gut Liver. 2022. PMID: 35791797 Free PMC article. Clinical Trial.
Can rebamipide and proton pump inhibitor combination therapy promote the healing of endoscopic submucosal dissection-induced ulcers? A randomized, prospective, multicenter study.
Shin WG, Kim SJ, Choi MH, Kim KO, Jang HJ, Park CH, Baek IH, Kim KH, Baik GH, Kae SH, Kim JH, Kim HY. Shin WG, et al. Among authors: kim hy, kim ko, kim sj, kim kh, kim jh. Gastrointest Endosc. 2012 Apr;75(4):739-47. doi: 10.1016/j.gie.2011.11.004. Epub 2012 Jan 26. Gastrointest Endosc. 2012. PMID: 22281110 Clinical Trial.
Comparison of the Eradication Rate between 1- and 2-Week Bismuth-Containing Quadruple Rescue Therapies for Helicobacter pylori Eradication.
Yoon JH, Baik GH, Kim YS, Suk KT, Shin WG, Kim KH, Kim KO, Park CH, Baik IH, Jang HJ, Kim JB, Kae SH, Kim DJ, Kim HY. Yoon JH, et al. Among authors: kim hy, kim ko, kim dj, kim jb, kim ys, kim kh. Gut Liver. 2012 Oct;6(4):434-9. doi: 10.5009/gnl.2012.6.4.434. Epub 2012 Oct 18. Gut Liver. 2012. PMID: 23170146 Free PMC article.
[Efficacy of fenoverine and trimebutine in the management of irritable bowel syndrome: multicenter randomized double-blind non-inferiority clinical study].
Kang SH, Jeen YT, Koo JS, Koo YS, Kim KO, Kim YS, Kim SY, Moon JS, Park JJ, Baek IH, Park SC, Lee SJ, Lee JH, Choung RS, Choi SC. Kang SH, et al. Among authors: kim ko, kim sy, kim ys. Korean J Gastroenterol. 2013 Nov;62(5):278-87. doi: 10.4166/kjg.2013.62.5.278. Korean J Gastroenterol. 2013. PMID: 24262593 Free article. Clinical Trial. Korean.
A comparative study of DA-9601 and misoprostol for prevention of NSAID-associated gastroduodenal injury in patients undergoing chronic NSAID treatment.
Lee OY, Kang DH, Lee DH, Chung IK, Jang JY, Kim JI, Cho JW, Rew JS, Lee KM, Kim KO, Choi MG, Lee SW, Lee ST, Kim TO, Shin YW, Seol SY. Lee OY, et al. Among authors: kim ji, kim ko, kim to. Arch Pharm Res. 2014 Oct;37(10):1308-16. doi: 10.1007/s12272-014-0408-3. Epub 2014 May 30. Arch Pharm Res. 2014. PMID: 24871787 Free PMC article. Clinical Trial.
Ten-day empirical sequential or concomitant therapy is more effective than triple therapy for Helicobacter pylori eradication: A multicenter, prospective study.
Chung JW, Han JP, Kim KO, Kim SY, Hong SJ, Kim TH, Kim CW, Kim JS, Kim BW, Bang BW, Kim HG, Yun SC; Incheon and Western Kyonggi Gastrointestinal Study Group. Chung JW, et al. Among authors: kim hg, kim ko, kim th, kim cw, kim bw, kim sy, kim js. Dig Liver Dis. 2016 Aug;48(8):888-92. doi: 10.1016/j.dld.2016.05.005. Epub 2016 May 16. Dig Liver Dis. 2016. PMID: 27257049 Clinical Trial.
563 results